ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,243Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 680

$604K Total Retail Price of All Prescriptions

Rank: 212 out of 680

443 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 705 587 1 1
LEVOTHYROXINE SODIUM 518 465 2 2
OMEPRAZOLE 395 343 3 7
METFORMIN HCL 373 325 4 8
ATORVASTATIN CALCIUM 355 313 5 11
HYDROCHLOROTHIAZIDE 345 280 6 9
METOPROLOL SUCCINATE 320 273 7 13
LOVASTATIN 312 294 8 44
FUROSEMIDE 312 282 8 6
ZOLPIDEM TARTRATE 268 207 10 17
HYDROCODONE-ACETAMINOPHEN 241 195 S3 11 4
LISINOPRIL 222 159 12 5
CRESTOR 217 176 13 25
PRAVASTATIN SODIUM 216 185 14 10
ATENOLOL 192 162 15 19
FLUTICASONE PROPIONATE 180 151 16 41
TRAMADOL HCL 170 142 17 18
GABAPENTIN 169 145 18 15
GLIMEPIRIDE 168 143 19 29
SIMVASTATIN 166 137 20 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 166 150 20 37
SERTRALINE HCL 158 134 22 28
PANTOPRAZOLE SODIUM 157 143 23 30
METOPROLOL TARTRATE 150 148 24 12
CIPROFLOXACIN HCL 146 127 25 57
SPIRONOLACTONE 127 108 26 82
RANITIDINE HCL 127 112 26 56
LOSARTAN POTASSIUM 121 97 28 21
CARVEDILOL 118 88 29 23
CLONIDINE HCL 114 97 30 36
GLIPIZIDE 112 94 31 63
CLOPIDOGREL 107 86 32 26
ALLOPURINOL 106 99 33 33
AZITHROMYCIN 104 76 34 42
DIOVAN 104 104 34 31
CITALOPRAM HBR 102 94 36 22
BYSTOLIC 100 91 37 79
MELOXICAM 100 93 37 24
NEXIUM 98 71 39 16
SINGULAIR 92 83 40 91
DIOVAN HCT 89 84 41 55
SYNTHROID 83 71 42 38
LANTUS SOLOSTAR 80 42 43 84
NAMENDA 80 80 43 35
PLAVIX 77 68 45 39
SPIRIVA 76 70 46 70
ADVAIR DISKUS 76 69 46 53
DOXYCYCLINE HYCLATE 73 55 48 95
HYDRALAZINE HCL 68 45 49 71
VERAPAMIL ER 68 57 49 100
PROAIR HFA 64 50 51 67
JANUVIA 62 61 52 60
BENAZEPRIL HCL 62 50 52 40
TRIAMTERENE-HCTZ 58 53 54 52
LOSARTAN-HYDROCHLOROTHIAZIDE 58 49 54 51
GLYBURIDE-METFORMIN HCL 58 56 R 54 107
POTASSIUM CHLORIDE 58 48 54 14
MONTELUKAST SODIUM 56 51 58 157
ISOSORBIDE MONONITRATE ER 56 47 58 59
TAMSULOSIN HCL 55 55 60 34
DONEPEZIL HCL 53 53 61 27
CELEBREX 52 50 62 90
ESCITALOPRAM OXALATE 51 48 63 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.